|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
|
EP0954585B1
(en)
|
1996-10-01 |
2009-11-25 |
Geron Corporation |
Human telomerase reverse transcriptase promoter
|
|
US6475789B1
(en)
*
|
1996-10-01 |
2002-11-05 |
University Technology Corporation |
Human telomerase catalytic subunit: diagnostic and therapeutic methods
|
|
US7585622B1
(en)
|
1996-10-01 |
2009-09-08 |
Geron Corporation |
Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
|
US6228640B1
(en)
|
1997-02-07 |
2001-05-08 |
Cem Cezayirli |
Programmable antigen presenting cell of CD34 lineage
|
|
US6251665B1
(en)
|
1997-02-07 |
2001-06-26 |
Cem Cezayirli |
Directed maturation of stem cells and production of programmable antigen presenting dentritic cells therefrom
|
|
US6977073B1
(en)
|
1997-02-07 |
2005-12-20 |
Cem Cezayirli |
Method for stimulating an immune response
|
|
US20020041868A1
(en)
*
|
1997-04-15 |
2002-04-11 |
Charles Nicolette |
Cell fusions and methods of making and using the same
|
|
US20050169898A1
(en)
*
|
1997-04-15 |
2005-08-04 |
Jianlin Gong |
Cell fusions and methods of making and using the same
|
|
US7413864B2
(en)
*
|
1997-04-18 |
2008-08-19 |
Geron Corporation |
Treating cancer using a telomerase vaccine
|
|
US7622549B2
(en)
*
|
1997-04-18 |
2009-11-24 |
Geron Corporation |
Human telomerase reverse transcriptase polypeptides
|
|
US6977074B2
(en)
*
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
EP1068296B1
(en)
|
1998-03-31 |
2011-08-10 |
Geron Corporation |
Compositions for eliciting an immune response to a telomerase antigen
|
|
US7402307B2
(en)
*
|
1998-03-31 |
2008-07-22 |
Geron Corporation |
Method for identifying and killing cancer cells
|
|
US6337200B1
(en)
*
|
1998-03-31 |
2002-01-08 |
Geron Corporation |
Human telomerase catalytic subunit variants
|
|
US20040247662A1
(en)
*
|
1998-06-25 |
2004-12-09 |
Dow Steven W. |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030022854A1
(en)
*
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
FR2785542B1
(fr)
*
|
1998-11-06 |
2001-02-09 |
Pf Medicament |
UTILISATION D'UNE PROTEINE OmpA D'ENTEROBACTERIE, POUR LE CIBLAGE SPECIFIQUE D'UNE SUBSTANCE BIOLOGIQUEMENT ACTIVE QUI LUI EST ASSOCIEE VERS LES CELLULES PRESENTATRICES D'ANTIGENES TELLES QUE LES CELLULES DENDRITIQUES HUMAINES
|
|
US7713739B1
(en)
|
2000-11-17 |
2010-05-11 |
Novartis Vaccines And Diagnostics, Inc. |
Microparticle-based transfection and activation of dendritic cells
|
|
US7015204B1
(en)
*
|
1999-10-07 |
2006-03-21 |
Cornell Research Foundation, Inc. |
Protective immunity or immunological tolerance induced with RNA particularly total cellular RNA
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US7541184B2
(en)
|
2000-02-24 |
2009-06-02 |
Invitrogen Corporation |
Activation and expansion of cells
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
AU2002258379A1
(en)
*
|
2000-10-24 |
2002-09-19 |
Whitehead Institute For Biomedical Research |
Response of dendritic cells to a diverse set of pathogens
|
|
EP1363931A4
(en)
*
|
2001-02-01 |
2004-04-07 |
Tanox Inc |
METHOD FOR THE PRODUCTION AND IDENTIFICATION OF MONOCLONAL ANTIBODIES AGAINST A LARGE NUMBER OF HUMAN ANTIGENS
|
|
DE10112851C1
(de)
|
2001-03-16 |
2002-10-10 |
Gsf Forschungszentrum Umwelt |
Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen
|
|
US20030082806A1
(en)
*
|
2001-04-27 |
2003-05-01 |
Xcyte Therapies, Inc. |
Maturation of antigen-presenting cells using activated T cells
|
|
GB0111015D0
(en)
*
|
2001-05-04 |
2001-06-27 |
Norsk Hydro As |
Genetic material
|
|
PT1857122E
(pt)
|
2001-06-05 |
2011-03-07 |
Curevac Gmbh |
Arnm estabilizado com teor de g/c aumentado, codificando para um antigénio viral
|
|
DE60233061D1
(de)
*
|
2001-09-06 |
2009-09-03 |
Alphavax Inc |
Alphavirus replikon-vektorsysteme
|
|
EP1442125A4
(en)
*
|
2001-10-04 |
2004-12-08 |
Carlos Estuard Aguilar-Cordova |
CHIMERAL VIRUS VECTORS FOR GENE THERAPY
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
CA2491574A1
(en)
*
|
2002-07-05 |
2004-01-15 |
Duke University |
Angio-immunotherapy
|
|
AU2003278709A1
(en)
*
|
2002-08-14 |
2004-03-03 |
Duke University |
Method of enhancing cd4+ t cell responses
|
|
CN103073620B
(zh)
|
2002-09-12 |
2014-12-10 |
肿瘤疗法科学股份有限公司 |
Kdr肽和包括该肽的疫苗
|
|
WO2004053095A2
(en)
*
|
2002-12-10 |
2004-06-24 |
Merix Bioscience, Inc. |
In situ maturation of dendritic cells
|
|
CA2807515C
(en)
*
|
2002-12-13 |
2014-02-04 |
Alphavax, Inc. |
Alphavirus particles and methods for preparation
|
|
US20040208848A1
(en)
*
|
2002-12-13 |
2004-10-21 |
Smith Jonathan F. |
Multi-antigenic alphavirus replicon particles and methods
|
|
US7404950B2
(en)
*
|
2003-02-18 |
2008-07-29 |
Baylor College Of Medicine |
Induced activation in dendritic cell
|
|
US20060134067A1
(en)
*
|
2003-02-18 |
2006-06-22 |
Maxcyte, Inc. |
Loading of cells with antigens by electroporation
|
|
EP1597390A4
(en)
*
|
2003-02-18 |
2006-12-27 |
Maxcyte Inc |
LOADING CELLS WITH ANTIGENES BY ELECTROPORATION
|
|
WO2004085660A2
(en)
*
|
2003-03-20 |
2004-10-07 |
Alphavax, Inc. |
Improved alphavirus replicons and helper constructs
|
|
ES2327643T3
(es)
*
|
2003-07-11 |
2009-11-02 |
Alphavax, Inc. |
Vacunas contra citomegalovirus basadas en alfavirus.
|
|
DE10335833A1
(de)
|
2003-08-05 |
2005-03-03 |
Curevac Gmbh |
Transfektion von Blutzellen mit mRNA zur Immunstimulation und Gentherapie
|
|
KR20060126516A
(ko)
*
|
2003-11-25 |
2006-12-07 |
아르고스 쎄라퓨틱스 인코포레이티드 |
Ｍｒｎａ로 전달이입된 항원제시세포
|
|
US20050181035A1
(en)
*
|
2004-02-17 |
2005-08-18 |
Dow Steven W. |
Systemic immune activation method using non CpG nucleic acids
|
|
US20050238627A1
(en)
*
|
2004-03-02 |
2005-10-27 |
Tsuneya Ohno |
Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
|
|
PT1751289E
(pt)
|
2004-05-18 |
2009-03-31 |
Alphavax Inc |
Vectores de alfavirais derivados da tc-83, partículas e métodos
|
|
WO2005116261A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Albert Einstein College Of Medecine Of Yeshiva University |
Rna expression microarrays
|
|
CA2504451A1
(en)
*
|
2004-08-10 |
2006-02-10 |
Geron Corporation |
Dendritic cell vaccines for treating cancer made from embryonic stem cells
|
|
EP2742951B1
(en)
*
|
2004-09-14 |
2016-02-03 |
Argos Therapeutics, Inc. |
Strain independent amplification of HIV polynucleotides
|
|
US8076132B2
(en)
|
2004-09-17 |
2011-12-13 |
Hasumi International Research Foundation |
Dendritic cell tumor injection (DCTI) therapy
|
|
US20060216269A1
(en)
*
|
2004-09-17 |
2006-09-28 |
Kenichiro Hasumi |
Dendritic cell tumor injection (DCTI) therapy
|
|
GB0501129D0
(en)
*
|
2005-01-19 |
2005-02-23 |
Ribostem Ltd |
Method of treatment by administration of RNA
|
|
ES2459466T3
(es)
|
2005-02-25 |
2014-05-09 |
Oncotherapy Science, Inc. |
Vacunas de péptidos para cánceres de pulmón que expresan polipéptidos TTK, URLC10 o KOC1
|
|
PT1855707E
(pt)
|
2005-02-28 |
2012-05-25 |
Oncotherapy Science Inc |
Péptidos de epítopo derivados de receptor de factor de crescimento endotelial vascular 1 e vacinas contendo estes péptidos
|
|
MX2007012221A
(es)
|
2005-04-08 |
2008-03-18 |
Argos Therapeutics Inc |
Composicion de celulas dendriticas y metodos.
|
|
US8674059B2
(en)
|
2005-07-27 |
2014-03-18 |
Oncotherapy Science, Inc. |
Colon cancer related gene TOM34
|
|
CA2626238C
(en)
|
2005-10-17 |
2015-10-06 |
Sloan Kettering Institute For Cancer Research |
Wt1 hla class ii-binding peptides and compositions and methods comprising same
|
|
PL2010209T3
(pl)
|
2006-04-10 |
2017-04-28 |
Sloan Kettering Inst For Cancer Res |
Immunogeniczne peptydy WT-1 i sposoby ich użycia
|
|
US20070281336A1
(en)
*
|
2006-04-14 |
2007-12-06 |
Epicentre Technologies |
Kits and methods for generating 5' capped RNA
|
|
JP5570808B2
(ja)
|
2006-08-18 |
2014-08-13 |
アルゴス・セラピューティクス・インコーポレーテッド |
併用療法におけるｃｄ８３の使用
|
|
KR101454287B1
(ko)
|
2006-10-17 |
2014-11-04 |
온코세라피 사이언스 가부시키가이샤 |
Ｍｐｈｏｓｐｈ1 또는 ｄｅｐｄｃ1 폴리펩티드를 발현하는 암에 대한 펩티드 백신
|
|
EP2076272B1
(en)
*
|
2006-10-19 |
2015-07-29 |
Baylor College Of Medicine |
Generating an immune response by inducing cd40 and pattern recognition receptors
|
|
WO2008055354A1
(en)
*
|
2006-11-10 |
2008-05-15 |
Université de Montréal |
Rna-loaded dendritic cell compositions for eliciting cd4+ t cell help and related methods
|
|
TWI610939B
(zh)
|
2007-02-21 |
2018-01-11 |
腫瘤療法 科學股份有限公司 |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
TW201425333A
(zh)
|
2007-04-11 |
2014-07-01 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌８胜肽及包含此胜肽之疫苗
|
|
EP2183368B1
(en)
|
2007-06-21 |
2016-08-10 |
Alphavax, Inc. |
Promoterless cassettes for expression of alphavirus structural proteins
|
|
RU2487886C2
(ru)
|
2007-08-20 |
2013-07-20 |
Онкотерапи Сайенс, Инк. |
Пептид foxm1 и включающее его медицинское средство
|
|
US8513208B2
(en)
*
|
2008-02-28 |
2013-08-20 |
Argos Therapeutics, Inc. |
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection
|
|
CN102123732A
(zh)
|
2008-06-20 |
2011-07-13 |
杜克大学 |
用于引发免疫应答的组合物，方法及试剂盒
|
|
ES2633470T3
(es)
*
|
2008-09-22 |
2017-09-21 |
Baylor College Of Medicine |
Métodos y composiciones de generación de una respuesta inmune mediante la inducción de CD40 y adaptadores de receptores de reconocimiento de patrones
|
|
CA2743669C
(en)
|
2008-11-24 |
2018-10-16 |
Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) |
High affinity t cell receptor and use thereof
|
|
TWI500932B
(zh)
|
2008-12-05 |
2015-09-21 |
Oncotherapy Science Inc |
Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
|
|
US8728806B2
(en)
|
2008-12-06 |
2014-05-20 |
The Board Of Regents, The University Of Texas System |
Methods and compositions related to Th-1 dendritic cells
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Ｆｏｘｍ１胜肽以及含此胜肽之疫苗
|
|
US9841426B2
(en)
*
|
2009-03-11 |
2017-12-12 |
Marker Gene Technologies, Inc |
Intracellular organelle peptide targeted enzyme substrates
|
|
RU2733985C2
(ru)
|
2009-03-18 |
2020-10-09 |
Онкотерапи Сайенс, Инк. |
Пептиды neil3 и включающие их вакцины
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Ｃｄｃ４５ｌ胜肽與含此胜肽之疫苗
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
JP5838482B2
(ja)
|
2010-03-11 |
2016-01-06 |
オンコセラピー・サイエンス株式会社 |
Ｈｊｕｒｐペプチドおよびそれを含むワクチン
|
|
TW201627003A
(zh)
|
2010-04-02 |
2016-08-01 |
腫瘤療法 科學股份有限公司 |
Ｅｃｔ２胜肽及含此胜肽之疫苗
|
|
US9089520B2
(en)
|
2010-05-21 |
2015-07-28 |
Baylor College Of Medicine |
Methods for inducing selective apoptosis
|
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
MX2013003681A
(es)
|
2010-10-01 |
2013-11-20 |
Moderna Therapeutics Inc |
Ácidos nucleicos manipulados y métodos de uso de los mismos.
|
|
DE12722942T1
(de)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
|
EP2557089A2
(en)
|
2011-07-15 |
2013-02-13 |
Fundació Institut d'Investigació Biomèdica de Bellvitge (IDIBELL) |
Compositions and methods for immunomodulation
|
|
DK2742133T3
(en)
|
2011-08-12 |
2017-12-04 |
Oncotherapy Science Inc |
MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THESE
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
SI3682905T1
(sl)
|
2011-10-03 |
2022-04-29 |
Modernatx, Inc. |
Modificirani nukleozidi, nukleotidi in nukleinske kisline ter njihove uporabe
|
|
MX355759B
(es)
|
2011-10-28 |
2018-04-27 |
Oncotherapy Science Inc |
Peptidos topk y vacunas que incluyen los mismos.
|
|
US20130156849A1
(en)
|
2011-12-16 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
|
US20150104413A1
(en)
|
2012-01-13 |
2015-04-16 |
Memorial Sloan Kettering Cancer Center |
Immunogenic wt-1 peptides and methods of use thereof
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
HK1206601A1
(en)
|
2012-04-02 |
2016-01-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
EP2872530A4
(en)
|
2012-07-10 |
2016-04-06 |
Oncotherapy Science Inc |
KIF20A EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
|
|
SI2922554T1
(sl)
|
2012-11-26 |
2022-06-30 |
Modernatx, Inc. |
Terminalno modificirana RNA
|
|
US10815273B2
(en)
|
2013-01-15 |
2020-10-27 |
Memorial Sloan Kettering Cancer Center |
Immunogenic WT-1 peptides and methods of use thereof
|
|
DK2945647T3
(da)
|
2013-01-15 |
2020-11-16 |
Memorial Sloan Kettering Cancer Center |
Immunogene wt-1-peptider og anvendelsesmetoder deraf
|
|
US9434935B2
(en)
|
2013-03-10 |
2016-09-06 |
Bellicum Pharmaceuticals, Inc. |
Modified caspase polypeptides and uses thereof
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Ｋｎｔｃ２胜肽及含此胜肽之疫苗
|
|
US9944690B2
(en)
|
2013-03-14 |
2018-04-17 |
Bellicum Pharmaceuticals, Inc. |
Methods for controlling T cell proliferation
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
CA2912172A1
(en)
|
2013-06-05 |
2014-12-11 |
Bellicum Pharmaceuticals, Inc. |
Methods for inducing partial apoptosis using caspase polypeptides
|
|
EP3049092A4
(en)
|
2013-09-24 |
2017-09-06 |
Duke University |
Compositions, methods and kits for eliciting an immune response
|
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
SG11201602503TA
(en)
|
2013-10-03 |
2016-04-28 |
Moderna Therapeutics Inc |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015062738A1
(en)
|
2013-11-01 |
2015-05-07 |
Curevac Gmbh |
Modified rna with decreased immunostimulatory properties
|
|
JP6772063B2
(ja)
|
2014-02-14 |
2020-10-21 |
ベリカム ファーマシューティカルズ， インコーポレイテッド |
誘導可能なキメラポリペプチドを使用して細胞を活性化するための方法
|
|
WO2016014613A1
(en)
*
|
2014-07-22 |
2016-01-28 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods for cancer immunotherapy
|
|
EP3178837B1
(en)
|
2014-08-04 |
2021-01-13 |
Oncotherapy Science, Inc. |
Urlc10-derived peptide and vaccine containing same
|
|
CN113321703A
(zh)
|
2014-08-04 |
2021-08-31 |
肿瘤疗法科学股份有限公司 |
Cdca1衍生的肽和含有它们的疫苗
|
|
AU2015300256B2
(en)
|
2014-08-04 |
2020-01-30 |
Oncotherapy Science, Inc. |
KOC1-Derived peptide and vaccine including same
|
|
US10888608B2
(en)
|
2014-09-02 |
2021-01-12 |
Bellicum Pharmaceuticals, Inc. |
Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides
|
|
WO2016044530A1
(en)
*
|
2014-09-17 |
2016-03-24 |
The Johns Hopkins University |
Reagents and methods for identifying, enriching, and/or expanding antigen-specific t cells
|
|
JP7005346B2
(ja)
*
|
2014-10-27 |
2022-02-04 |
フレッド ハッチンソン キャンサー リサーチ センター |
養子細胞免疫療法の有効性を増強させるための組成物および方法
|
|
ES2904301T3
(es)
|
2014-11-03 |
2022-04-04 |
Academisch Ziekenhuis Leiden H O D N Leids Univ Medisch Centrum |
Receptores de células T dirigidos contra Bob1 y usos de los mismos
|
|
JP2018090491A
(ja)
*
|
2015-04-01 |
2018-06-14 |
株式会社細胞治療技術研究所 |
癌ワクチンの製造方法、及び癌ワクチン
|
|
US11090332B2
(en)
*
|
2015-05-21 |
2021-08-17 |
Regen BioPharma, Inc. |
Antigen specific mRNA cellular cancer vaccines
|
|
JP6666094B2
(ja)
*
|
2015-09-15 |
2020-03-13 |
株式会社東芝 |
吸着支持装置、および物品把持装置
|
|
MX2018004308A
(es)
|
2015-10-08 |
2018-05-01 |
Oncotherapy Science Inc |
Peptido derivado de foxm1 y vacuna que lo incluye.
|
|
EP3410849B1
(en)
|
2016-02-05 |
2023-07-05 |
Institut Pasteur |
Use of inhibitors of adam12 as adjuvants in tumor therapies
|
|
CA3022267A1
(en)
|
2016-05-04 |
2017-11-09 |
Fred Hutchinson Cancer Research Center |
Cell-based neoantigen vaccines and uses thereof
|
|
WO2018005769A1
(en)
*
|
2016-06-29 |
2018-01-04 |
Duke University |
Compositions and methods for activating antigen presenting cells with chimeric poliovirus
|
|
WO2019135701A1
(en)
*
|
2018-01-05 |
2019-07-11 |
Nilsson Rolf Jonas Andreas |
Endogenous tumor-derived circular rna and proteins thereof for use as vaccine
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
WO2025101584A1
(en)
*
|
2023-11-06 |
2025-05-15 |
Immunitybio, Inc. |
Virally educated t cells
|